![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, June 20, 2020 4:57:05 PM
I know since today we have no commercial products and revenue is zero dividends don't cross the minds of many, in the future that should all change.
Let's look into the future 3 years from now: Brilacidin is now a major factor in IBD, COPD/Asthma, Kidney infections, dermatology uses, OM, brain inflammation, burn cases, CV19, Flu, and all other viruses, etc, etc.
Kevetrin has been developed into a pill and has been in a flurry of complementary trials with all current cancer treatments and as a stand alone product. I believe that is still a large ? to all but IMO it will be found to be quite effective and thus very, very valuable.
Who does not think both Brilacidin Kevetrin with both their efficacy and safety profiles will not be able to take a very nice piece of each of these areas of medicine?
So just for the sake of establishing a scenario, say they capture 25% of each market.
Say for the scenario they get a royalty rate of 20% (some may think this is high but I don't see Leo partnering any indication prior to P3 so with their safety profiles the risk should be about gone and the BPs should pay a higher than normal royalty rate.
Again, for this scenario lets have shares at 333MM and revenues at $5B/yr (I again think this is quite a conservative scenario).
What would expenditures be for a company with less than a handful of employees or only a greater number mainly in accounting areas, no facilities, no healthcare or retirement benefits of note to pay, etc? For the amount of revenues, expenditures will be next to immaterial at that time.
So take $5B/333MM shares and that is $15/yr in dividends.
I will again go hogwild conservative and cut the dividends to $10/yr. (This effectively reduces revenues to 3.5B/yr or so)
So a person with 50K shares would be receiving $500K/yr.
A person with only 10K shares $100K/yr.
Personally, that leaves many of us with large holdings having generational wealth in that it never has to be touched as the dividends alone should provide a great lifestyle for anyone.
The above is why I am not hellbent on selling the company right away.
But then again, I am an investor. Most of those now on the board are traders and want to make a quick buck and run. Leo isn't among them.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM